Prediction platform, Kalshi, just launched a new pilot program allowing users to buy "Yes" or "No" contracts on whether highly anticipated clinical trials will succeed or if the FDA will greenlight new treatments. While proponents say it will bring much-needed transparency to opaque drug pipelines, critics are raising major red flags over potential insider trading and market manipulation. Would you wager your money on the future of medicine, or is gamifying FDA approvals crossing a line? Drop your thoughts below! 👇 #Biotech #PredictionMarkets #Finance #FDA #Trading